262 related articles for article (PubMed ID: 30240328)
21. Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause.
Vega JN; Dumas J; Newhouse PA
Psychooncology; 2018 Sep; 27(9):2198-2205. PubMed ID: 29904964
[TBL] [Abstract][Full Text] [Related]
22. Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls.
Wang L; Apple AC; Schroeder MP; Ryals AJ; Voss JL; Gitelman D; Sweet JJ; Butt ZA; Cella D; Wagner LI
Cancer; 2016 Jan; 122(2):258-68. PubMed ID: 26484435
[TBL] [Abstract][Full Text] [Related]
23. Protocol for the "Chemobrain in Motion - study" (CIM - study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive impairments in women with breast cancer receiving first-line chemotherapy.
Oberste M; Schaffrath N; Schmidt K; Bloch W; Jäger E; Steindorf K; Hartig P; Joisten N; Zimmer P
BMC Cancer; 2018 Nov; 18(1):1071. PubMed ID: 30400840
[TBL] [Abstract][Full Text] [Related]
24. Associations of brain-derived neurotrophic factor rs6265 polymorphism and cognitive function in breast cancer survivors from a cross-sectional study.
Goto T; Saligan LN; Li X; Xiang L; Kwiat C; Nguyen C; Crouch A; Von Ah D
Cancer Med; 2024 Jan; 13(2):e6975. PubMed ID: 38379321
[TBL] [Abstract][Full Text] [Related]
25. Biological and psychological predictors of cognitive function in breast cancer patients before surgery.
Aspelund SG; Halldorsdottir T; Agustsson G; Sigurdardottir Tobin HR; Wu LM; Amidi A; Johannsdottir KR; Lutgendorf SK; Telles R; Daly HF; Sigurdardottir K; Valdimarsdottir HB; Baldursdottir B
Support Care Cancer; 2024 Jan; 32(1):88. PubMed ID: 38185720
[TBL] [Abstract][Full Text] [Related]
26. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.
Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL
J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061
[TBL] [Abstract][Full Text] [Related]
27. The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study.
Lyon DE; Cohen R; Chen H; Kelly DL; Starkweather A; Ahn HC; Jackson-Cook CK
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1461-74. PubMed ID: 27102492
[TBL] [Abstract][Full Text] [Related]
28. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients.
Jansen CE; Cooper BA; Dodd MJ; Miaskowski CA
Support Care Cancer; 2011 Oct; 19(10):1647-56. PubMed ID: 20820813
[TBL] [Abstract][Full Text] [Related]
29. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
30. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.
Cheung YT; Ng T; Shwe M; Ho HK; Foo KM; Cham MT; Lee JA; Fan G; Tan YP; Yong WS; Madhukumar P; Loo SK; Ang SF; Wong M; Chay WY; Ooi WS; Dent RA; Yap YS; Ng R; Chan A
Ann Oncol; 2015 Jul; 26(7):1446-51. PubMed ID: 25922060
[TBL] [Abstract][Full Text] [Related]
31. An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.
Cheung YT; Tan EH; Chan A
Support Care Cancer; 2012 Jul; 20(7):1361-75. PubMed ID: 22476439
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy.
Toh YL; Tan CJ; Yap NY; Parajuli R; Lau AJ; Chan A
Sci Rep; 2022 Oct; 12(1):16552. PubMed ID: 36192413
[TBL] [Abstract][Full Text] [Related]
33. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
34. Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial.
Juan Z; Chen J; Ding B; Yongping L; Liu K; Wang L; Le Y; Liao Q; Shi J; Huang J; Wu Y; Ma D; Ouyang W; Tong J
Eur J Cancer; 2022 Jan; 161():10-22. PubMed ID: 34896904
[TBL] [Abstract][Full Text] [Related]
35. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
36. Cancer-related cognitive impairment and associated factors in a sample of older male oral-digestive cancer survivors.
Regier NG; Naik AD; Mulligan EA; Nasreddine ZS; Driver JA; Sada YH; Moye J
Psychooncology; 2019 Jul; 28(7):1551-1558. PubMed ID: 31134710
[TBL] [Abstract][Full Text] [Related]
37. Use of focused computerized cognitive training (Neuroflex) to improve symptoms in women with persistent chemotherapy-related cognitive impairment.
Vega JN; Newhouse PA; Conley AC; Szymkowicz SM; Gong X; Cote S; Mayer I; Taylor WD; Morimoto SS
Digit Health; 2023; 9():20552076231192754. PubMed ID: 37588161
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
Fischer B
Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
[TBL] [Abstract][Full Text] [Related]
39. Self-reported cognitive outcomes among adolescent and young adult patients with noncentral nervous system cancers.
Tan CJ; Mah JJJ; Goh WL; Poon E; Harunal Rashid MF; Chan A
Psychooncology; 2020 Aug; 29(8):1355-1362. PubMed ID: 32597001
[TBL] [Abstract][Full Text] [Related]
40. Cognitive impairment in hodgkin lymphoma survivors.
Trachtenberg E; Mashiach T; Ben Hayun R; Tadmor T; Fisher T; Aharon-Peretz J; Dann EJ
Br J Haematol; 2018 Sep; 182(5):670-678. PubMed ID: 29974933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
